Royce & Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-974,439
| Closed | -$4.93M | – | 1205 |
|
|
2019
Q3 | $4.93M | Hold |
974,439
| – | – | 0.05% | 482 |
|
|
2019
Q2 | $6.01M | Sell |
974,439
-227,200
| -19% | -$1.4M | 0.05% | 449 |
|
|
2019
Q1 | $5.58M | Sell |
1,201,639
-195,000
| -14% | -$905K | 0.05% | 483 |
|
|
2018
Q4 | $5.87M | Sell |
1,396,639
-56,817
| -4% | -$239K | 0.05% | 463 |
|
|
2018
Q3 | $9.11M | Buy |
1,453,456
+276,200
| +23% | +$1.73M | 0.06% | 433 |
|
|
2018
Q2 | $9.47M | Buy |
1,177,256
+15,000
| +1% | +$121K | 0.07% | 409 |
|
|
2018
Q1 | $8.67M | Sell |
1,162,256
-48,600
| -4% | -$363K | 0.06% | 420 |
|
|
2017
Q4 | $7.21M | Sell |
1,210,856
-73,918
| -6% | -$440K | 0.05% | 490 |
|
|
2017
Q3 | $9.46M | Sell |
1,284,774
-61,600
| -5% | -$453K | 0.06% | 401 |
|
|
2017
Q2 | $9.14M | Buy |
1,346,374
+95,700
| +8% | +$650K | 0.06% | 419 |
|
|
2017
Q1 | $11.8M | Sell |
1,250,674
-208,500
| -14% | -$1.97M | 0.08% | 347 |
|
|
2016
Q4 | $12.6M | Sell |
1,459,174
-269,176
| -16% | -$2.33M | 0.08% | 321 |
|
|
2016
Q3 | $10.9M | Sell |
1,728,350
-185,000
| -10% | -$1.17M | 0.07% | 353 |
|
|
2016
Q2 | $8.07M | Sell |
1,913,350
-225,000
| -11% | -$949K | 0.05% | 449 |
|
|
2016
Q1 | $9.32M | Sell |
2,138,350
-143,900
| -6% | -$627K | 0.06% | 411 |
|
|
2015
Q4 | $14M | Sell |
2,282,250
-696,700
| -23% | -$4.27M | 0.08% | 317 |
|
|
2015
Q3 | $17M | Sell |
2,978,950
-242,900
| -8% | -$1.39M | 0.09% | 274 |
|
|
2015
Q2 | $24M | Buy |
3,221,850
+1,514,000
| +89% | +$11.3M | 0.1% | 258 |
|
|
2015
Q1 | $10.2M | Buy |
1,707,850
+25,000
| +1% | +$150K | 0.04% | 565 |
|
|
2014
Q4 | $12.7M | Buy |
1,682,850
+1,002,850
| +147% | +$7.58M | 0.04% | 520 |
|
|
2014
Q3 | $3.53M | Buy |
+680,000
| New | +$3.53M | 0.01% | 882 |
|